OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3020% below fair value
$1.68+0.01 (+0.60%)
Close on Nov 13, 2026Market cap $1.25BP/E –Yield –
OPKO Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
OPKO Health's enterprise value was $1.01B on Nov 11, 2026, against $582.69M a year earlier. Over the last 5 years it ranged from $484.61M to $2.96B, with a median of $919.97M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.01B | +97.9% |
| 2025 | Dec 31, 2025 | $509.84M | -33.3% |
| 2024 | Dec 31, 2024 | $764.19M | -24.0% |
| 2023 | Dec 29, 2023 | $1.01B | +46.6% |
| 2022 | Dec 30, 2022 | $686.48M | -76.8% |
| 2021 | Dec 31, 2021 | $2.96B | +19.2% |
| 2020 | Dec 31, 2020 | $2.48B | +211.3% |
| 2019 | Dec 31, 2019 | $796.73M | -51.5% |
| 2018 | Dec 31, 2018 | $1.64B | -38.8% |
| 2017 | Dec 29, 2017 | $2.68B | -46.1% |
| 2016 | Dec 30, 2016 | $4.98B | +9.8% |
| 2015 | Dec 31, 2015 | $4.53B | +12.1% |
| 2014 | Dec 31, 2014 | $4.05B | +57.0% |
| 2013 | Dec 31, 2013 | $2.58B | +90.9% |
| 2012 | Apr 30, 2012 | $1.35B | -7.2% |
| 2011 | Oct 31, 2011 | $1.46B | +79.0% |
| 2010 | Dec 31, 2010 | $813.16M | – |
See a number that looks wrong?